![FemTech Focus artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/45/c1/19/45c11996-5c35-71f9-02f6-0984c4597237/mza_10902202456499080144.png/100x100bb.jpg)
Prenatal genetic screening as a critical maternal health tool with Natera - Episode 172
FemTech Focus
English - July 18, 2022 05:00 - 49 minutes - 45.3 MB - ★★★★★ - 51 ratingsEducation Technology femtech health tech wellness womenshealth Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Data Privacy of FemTech Apps in a post Roe v Wade America - Bonus
Next Episode: BD's newest HPV screening assay - Episode 173
Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visitwww.natera.com.
@NateraGenetics, @NateraWomen